Population
Serum from atherosclerosis patients and oxidized low-density lipoprotein-induced human umbilical vein…
Comparison
circ_CHMP5 knockdown vs ox-LDL exposure alone / control
Design
Preclinical
Key result
Silencing of circ_CHMP5 reversed ox-LDL-induced inhibition of HUVEC proliferation and angiogenesis and reduced apoptosis via the miR-516b-5p/TGFβR2 axis.
Authors
Loading...
circ_CHMP5 axis in endothelial injury is hypothesis-generating; leaves open validation as biomarker or target in atherosclerosis.
Knockdown of circ_CHMP5 protects endothelial cells from ox-LDL-induced damage by modulating the miR-516b-5p/TGFβR2 axis, suggesting a potential therapeutic target for atherosclerosis.
Wang et al. (2023) studied Atherosclerosis. Circ_CHMP5 knockdown vs. ox-LDL-induced HUVECs without knockdown was evaluated on Cell proliferation, apoptosis, and tube formation. Silencing of circ_CHMP5 reversed ox-LDL-induced inhibition of HUVEC proliferation and angiogenesis and reduced apoptosis via the miR-516b-5p/TGFβR2 axis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: